The Renal Hemodynamic Effect of SGLT 2 Inhibition in Patients with Type 1 Diabetes

David Z. I. Cherney,Bruce A. Perkins,Nima Soleymanlou,Maria Maione,Vesta Lai, Alana Lee,Nora M. Fagan,Hans J. Woerle,Odd Erik Johansen,Uli C. Broedl,Maximilian von Eynatten

semanticscholar（2013）

引用 0|浏览0

暂无评分

摘要

Dept of Medicine, Division of Nephrology; Dept of Medicine, Division of Endocrinology, Toronto General Hospital, University of Toronto, Toronto, Canada; Boehringer Ingelheim Canada Ltd./Ltée, Burlington, Canada; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT; Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany *contributed equally as primary co-authors; †contributed equally as senior co-authors

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要